Continuing with our previous study, for the aims to find out the potential molecular biomarkers for NPC management, we defined the EBV latency-derived LMP-1, LMP-2 gene expression whether or not associated with NPC in Vietnamese NPC patients. This evidence concerns the gene PSMB9 and nasopharyngeal carcinoma.